Cannabis and Psychosis: a Critical Overview of the Relationship

Current Psychiatry Reports
Charles Ksir, Carl L Hart

Abstract

Interest in the relationship between cannabis use and psychosis has increased dramatically in recent years, in part because of concerns related to the growing availability of cannabis and potential risks to health and human functioning. There now exists a plethora of scientific articles addressing this issue, but few provide a clear verdict about the causal nature of the cannabis-psychosis association. Here, we review recent research reports on cannabis and psychosis, giving particular attention to how each report provides evidence relating to two hypotheses: (1) cannabis as a contributing cause and (2) shared vulnerability. Two primary kinds of data are brought to bear on this issue: studies done with schizophrenic patients and studies of first-episode psychosis. Evidence reviewed here suggests that cannabis does not in itself cause a psychosis disorder. Rather, the evidence leads us to conclude that both early use and heavy use of cannabis are more likely in individuals with a vulnerability to psychosis. The role of early and heavy cannabis use as a prodromal sign merits further examination, along with a variety of other problem behaviors (e.g., early or heavy use of cigarettes or alcohol and poor school performance). Future ...Continue Reading

References

May 20, 2008·Psychological Medicine·W VelingH W Hoek
Jul 2, 2008·Expert Review of Neurotherapeutics·Kirsten R Müller-Vahl, Hinderk M Emrich
Sep 29, 2009·The International Journal on Drug Policy·Jennifer A McLarenWayne Hall
Mar 27, 2012·Addictive Behaviors·Andrea L StoneRichard F Catalano
Dec 4, 2012·Schizophrenia Research·Nadia SolowijMurat Yücel
Feb 20, 2013·The Journal of Clinical Psychiatry·Jussi A Niemi-PynttäriSami P Pirkola
Jul 5, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Miquel BioqueUNKNOWN FLAMM-PEPs study—Centro de Investigacio´n Biome´dica en Red de Salud Mental
Jul 9, 2013·Biological Psychiatry·Lisa-Marie GreenwoodNadia Solowij
Jul 23, 2013·The International Journal on Drug Policy·Ian HamiltonChristine Godfrey
Jul 26, 2013·Schizophrenia Bulletin·Amber L BahorikShaun M Eack
Jul 31, 2013·JAMA Psychiatry·Karolina A AbergEdwin J van den Oord
Oct 3, 2013·European Archives of Psychiatry and Clinical Neuroscience·Berend MalchowThomas Wobrock
Oct 18, 2013·Frontiers in Psychiatry·Benjamin ChadwickYasmin L Hurd
Dec 7, 2013·Schizophrenia Research·Ashley C ProalLynn E Delisi
Jan 3, 2014·JAMA Psychiatry·Sarah M HartzUNKNOWN Genomic Psychiatry Cohort Consortium
Jan 28, 2014·Psychiatry Research·Kim DonoghueJames H Maccabe
Apr 2, 2014·Schizophrenia Research·Andrew Kenneth MartinBryan Mowry
May 7, 2014·Journal of Youth and Adolescence·Richard Jessor, Mark S Turbin
May 14, 2014·The Australian and New Zealand Journal of Psychiatry·Grant E SaraWayne C Hall
May 17, 2014·Schizophrenia Research·Nikos C StefanisVera A Morgan
Jun 25, 2014·Molecular Psychiatry·R A PowerN G Martin
Jul 24, 2014·Psychological Medicine·L R ValmaggiaP K McGuire
Aug 1, 2014·Frontiers in Psychiatry·Michel LejoyeuxMichaelle Ilongo
Aug 16, 2014·L'Encéphale·E GuillemF Bellivier
Sep 5, 2014·The American Journal on Addictions·Rachel A RabinTony P George
Dec 17, 2014·Journal of Psychiatry & Neuroscience : JPN·Laura KoendersLieuwe de Haan
Jan 13, 2015·Acta Psychiatrica Scandinavica·A M AutherB A Cornblatt

❮ Previous
Next ❯

Citations

May 9, 2016·The Lancet. Psychiatry·Charles Ksir, Carl L Hart
Oct 8, 2016·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Robin M MurrayMarta Di Forti
Jun 22, 2017·Neuropharmacology·R M MurrayD C D'Souza
Jun 22, 2017·Depression and Anxiety·Jasmine TurnaMichael Van Ameringen
Jun 15, 2017·The American Journal of Drug and Alcohol Abuse·Melanie RylanderAbraham Nussbaum
Jun 22, 2017·International Journal of Molecular Sciences·María A AguilarM Carmen Arenas
Aug 18, 2018·International Journal of Adolescent Medicine and Health·Paulina Riess, Leo Sher
Feb 3, 2018·European Archives of Psychiatry and Clinical Neuroscience·Valéria de Almeida, Daniel Martins-de-Souza
Dec 6, 2018·International Journal of Molecular Sciences·Anke HoffmannDietmar Spengler
May 14, 2019·Journal of Palliative Medicine·Maija ReblinKathleen M Egan
May 30, 2019·Nordic Journal of Psychiatry·Renata AlisauskieneErik Johnsen
Oct 22, 2019·The American Journal of Drug and Alcohol Abuse·Bryon Adinoff, Amanda Reiman
Dec 7, 2019·International Journal of Methods in Psychiatric Research·Manuel Gonçalves-PinhoAlberto Freitas
Dec 5, 2019·Social Psychiatry and Psychiatric Epidemiology·Megan S FarrisJean Addington
Nov 11, 2016·Current Rheumatology Reports·Mary-Ann Fitzcharles, Winfried Häuser
Oct 2, 2020·Addiction·Wayne Hall, Sarah Yeates
Jan 25, 2017·Case Reports in Psychiatry·Daniel Hernandez-HuertaHelen Dolengevich-Segal
Sep 30, 2019·European Archives of Psychiatry and Clinical Neuroscience·Alkomiet HasanEva Hoch
Oct 24, 2017·Current Addiction Reports·Kelly E CourtneyJoanna Jacobus
Apr 25, 2018·Translational Psychiatry·Boris GuennewigGuy Barry
Jun 13, 2020·Frontiers in Psychology·Marco ColizziSagnik Bhattacharyya
Dec 6, 2018·Frontiers in Molecular Neuroscience·Mario Stampanoni BassiEnnio Iezzi
Oct 31, 2019·International Journal of Environmental Research and Public Health·Nathan T Pearson, James H Berry
Dec 4, 2019·Addiction·Wayne Hall
Dec 8, 2020·Early Intervention in Psychiatry·Stephanie Coronado-MontoyaDidier Jutras-Aswad
Feb 11, 2021·Toxins·Zeinab BreijyehLaura Scrano
Feb 12, 2021·International Journal of Emergency Medicine·Kevin M Takakuwa, Raquel M Schears
Feb 23, 2021·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Sarah Kanana KiburiMichael T Lynskey
Feb 26, 2021·Nature Reviews. Disease Primers·Jason P ConnorWayne D Hall
Jun 22, 2020·Journal of Psychiatric Research·S MaderoM Balcells
May 12, 2021·Journal of Psychiatric Research·Stephan SolerJorge Lopez-Castroman
Aug 14, 2020·Progress in Neuro-psychopharmacology & Biological Psychiatry·Sierra J Stringfield, Mary M Torregrossa
May 3, 2020·Pediatrics·Kristie LadegardMelanie Rylander

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Psychoactive Drugs
Mohamed Ben Amar, Stéphane Potvin
Psychiatria Hungarica : A Magyar Pszichiátriai Társaság tudományos folyóirata
Péter Pajkossy, Zsolt Demetrovics
Schizophrenia Bulletin
Cécile HenquetRobin M Murray
© 2022 Meta ULC. All rights reserved